ICMR to participate in Solidarity trial by WHO

Indian Council for Medical Research, ICMR has fast tracked the roll out of Global Solidarity Trial launched by the World Health Organization, WHO to help in finding an effective treatment for Covid-19.

The international clinical trial ‘Solidarity’ compares four treatment options against the standard of care to assess their relative effectiveness against COVID-19.

Four potential anti-viral agents, Remdesivir, Chloroquine/Hydroxychloroquine, Lopinavir-Ritonavir, and Lopinavir-Ritonavir with Interferon will be evaluated in the trial.

The solidarity trial focuses to discover whether any of the drugs slow the disease’s progression or improve survival, by enrolling patients in multiple countries. This special feature of the initiative is it provides both speed and scale.

ICMR-National AIDS Research Institute (NARI) is the national coordination site for the trial in India.